AT266336B - Verfahren zur Herstellung von 3-Keto-4,6-bisdehydro-9-β,10α-steroiden - Google Patents

Verfahren zur Herstellung von 3-Keto-4,6-bisdehydro-9-β,10α-steroiden

Info

Publication number
AT266336B
AT266336B AT1033564A AT1033564A AT266336B AT 266336 B AT266336 B AT 266336B AT 1033564 A AT1033564 A AT 1033564A AT 1033564 A AT1033564 A AT 1033564A AT 266336 B AT266336 B AT 266336B
Authority
AT
Austria
Prior art keywords
bisdehydro
keto
steroids
preparation
Prior art date
Application number
AT1033564A
Other languages
English (en)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Application granted granted Critical
Publication of AT266336B publication Critical patent/AT266336B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT1033564A 1963-12-09 1964-12-07 Verfahren zur Herstellung von 3-Keto-4,6-bisdehydro-9-β,10α-steroiden AT266336B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL63301566A NL146503B (nl) 1963-12-09 1963-12-09 Werkwijze voor de bereiding van een 9beta, 10alfa-pregna-4,6-dieen-3,20-dion.

Publications (1)

Publication Number Publication Date
AT266336B true AT266336B (de) 1968-11-11

Family

ID=19755277

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1033564A AT266336B (de) 1963-12-09 1964-12-07 Verfahren zur Herstellung von 3-Keto-4,6-bisdehydro-9-β,10α-steroiden

Country Status (12)

Country Link
US (1) US3364205A (de)
AT (1) AT266336B (de)
BR (1) BR6465078D0 (de)
CH (1) CH491898A (de)
CS (1) CS150524B2 (de)
DE (1) DE1468427C3 (de)
DK (1) DK118818B (de)
ES (1) ES306848A1 (de)
FI (1) FI42326B (de)
GB (2) GB1096959A (de)
NL (1) NL146503B (de)
SE (2) SE335336B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107531746B8 (zh) * 2015-04-02 2023-11-10 台州市海盛制药有限公司 9β,10α-孕甾-4,6-二烯-3,20-二酮的制备方法
CN110790808B (zh) * 2019-11-19 2022-10-28 湖南新合新生物医药有限公司 一种5,7-孕甾二烯-3,20-二酮-二乙二缩酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL112521C (de) * 1960-05-30

Also Published As

Publication number Publication date
DE1468427C3 (de) 1974-05-02
ES306848A1 (es) 1965-05-16
SE330532B (de) 1970-11-23
CH491898A (de) 1970-06-15
GB1096959A (en) 1967-12-29
DK118818B (da) 1970-10-12
CS150524B2 (de) 1973-09-04
SE335336B (de) 1971-05-24
NL146503B (nl) 1975-07-15
FI42326B (de) 1970-03-31
BR6465078D0 (pt) 1973-08-02
DE1468427A1 (de) 1970-01-08
GB1096958A (en) 1967-12-29
US3364205A (en) 1968-01-16
DE1468427B2 (de) 1973-09-27

Similar Documents

Publication Publication Date Title
CH471134A (de) Verfahren zur Herstellung von Pyrazinoylbenzamidinen
CH464188A (de) Verfahren zur Herstellung von 3-Keto-4,6-bisdehydro-6-halogen-9B,10 -steroiden
CH458587A (de) Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon
CH479574A (de) Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden
CH460766A (de) Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden
AT244338B (de) Verfahren zur Herstellung von 3-Amino-isoxazolen
CH449610A (de) Verfahren zur Herstellung von Oestra-4,9-dien-3-olen
CH471829A (de) Verfahren zur Herstellung von 3-Hydroxy-1,5-bisdehydrosteroiden
CH426836A (de) Verfahren zur Herstellung von Naphthindolizinchinonen
CH430716A (de) Verfahren zur Herstellung von trans-2-Phenyl-3-methylmorpholin
AT266336B (de) Verfahren zur Herstellung von 3-Keto-4,6-bisdehydro-9-β,10α-steroiden
CH425809A (de) Verfahren zur Herstellung von Pyridazoniminen
CH416106A (de) Verfahren zur Herstellung von Polydodecalactam
AT247848B (de) Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen
CH433229A (de) Verfahren zur Herstellung von 2-Hydroxy-2,3-dihydrocitral
CH439328A (de) Verfahren zur Herstellung von 3,5-Dijodthyroninen
CH441583A (de) Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen
CH423764A (de) Verfahren zur Herstellung von 3-Keto- 4,6-Steroiden
CH482664A (de) Verfahren zur Herstellung von 6-Methyl- 14-pregnenen
CH431494A (de) Verfahren zur Herstellung von Alkenylanilinen
CH424793A (de) Verfahren zur Herstellung von 4-Nitro-5-hydroxy-pyridazonen-6
CH464907A (de) Verfahren zur Herstellung von 19-Hydroxy-4-androsten-3,17-dion
AT253703B (de) Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden
CH471056A (de) Verfahren zur Herstellung von 2,5-Dialkoxybenzaldehyden
CH451151A (de) Verfahren zur Herstellung von 1,4-Benzoxazin-2-onen